Considering that some patients did not accomplish entire adjuvant chemotherapy because of poor economic conditions, we stratified the analysis of the correlation between ARHGAP35 genotypes and osteosarcoma outcome by the radical treatment status to explore whether this difference affected the results (Figure 2). This evidence concerns the gene ARHGAP35 and osteosarcoma.